[Vaccines against human papillomavirus (HPV); between registration and implementation].

PubWeight™: 1.34‹?› | Rank: Top 10%

🔗 View Article (PMID 18549172)

Published in Ned Tijdschr Geneeskd on April 26, 2008

Authors

T G J van Rossum1, H E de Melker, H Houweling, A C G Voordouw, C J L M Meijer, Th J M Helmerhorst, M Kretzschmar, J Berkhof, J van der Noordaa

Author Affiliations

1: College ter Beoordeling van Geneesmiddelen, Den Haag. tg.v.rossum@cbg-meb.nl

Articles citing this

[A falsely reassuring cervical smear in adenocarcinoma of the external os]. Ned Tijdschr Geneeskd (2008) 2.02

Articles by these authors

Rapid and simple method for purification of nucleic acids. J Clin Microbiol (1990) 44.73

The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73

Concurrent partnerships and the spread of HIV. AIDS (1997) 10.73

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet (2005) 7.09

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet (2007) 5.81

Social contacts of school children and the transmission of respiratory-spread pathogens. Epidemiol Infect (2007) 3.59

Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. Br Med J (Clin Res Ed) (1986) 3.27

Is publication bias a medical problem? Lancet (1993) 3.04

Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus. Br Med J (Clin Res Ed) (1986) 2.75

The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol (2004) 2.63

Immunity to poliomyelitis in The Netherlands. Am J Epidemiol (2001) 2.60

Contact tracing in stochastic and deterministic epidemic models. Math Biosci (2000) 2.44

Human cytomegalovirus DNA. I. Molecular weight and infectivity. J Virol (1978) 2.43

Perspective: human contact patterns and the spread of airborne infectious diseases. Trends Microbiol (1999) 2.42

Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects. Lancet (1988) 2.38

Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer (2004) 2.33

Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands. Am J Epidemiol (1987) 2.32

Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis (2010) 2.26

[Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk]. Ned Tijdschr Geneeskd (2007) 2.26

Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer (2002) 2.25

Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14

Impact of HIV antibody testing on changes in sexual behavior among homosexual men in The Netherlands. Am J Public Health (1988) 2.07

Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. J Infect Dis (1988) 2.06

Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect (2002) 2.05

The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J Med Virol (1982) 2.04

[A falsely reassuring cervical smear in adenocarcinoma of the external os]. Ned Tijdschr Geneeskd (2008) 2.02

Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. Br Med J (Clin Res Ed) (1987) 2.02

Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol (2006) 2.02

[Universal vaccination against group-C meningococci and pneumococci; summary of the advice from the Health Counsil of the Netherlands]. Ned Tijdschr Geneeskd (2002) 2.00

Rapid purification of hepatitis B virus DNA from serum. J Clin Microbiol (1991) 1.97

The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies. Epidemiol Infect (2000) 1.86

Human cytomegalovirus DNA: physical maps for restriction endonucleases BglII, hindIII and XbaI. J Gen Virol (1980) 1.84

Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer (2006) 1.83

Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer (2002) 1.83

Papillomavirus infection in rural women in southern India. Br J Cancer (2005) 1.79

Length and tension transducers. J Physiol (1967) 1.76

Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer. Br J Cancer (2008) 1.69

Universal HIV screening of pregnant women in England: cost effectiveness analysis. BMJ (1999) 1.68

CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol (2004) 1.63

Human papillomavirus infection in Shenyang City, People's Republic of China: A population-based study. Br J Cancer (2006) 1.62

Second national serum bank for population-based seroprevalence studies in the Netherlands. Neth J Med (2009) 1.60

Apoptosis in myocardial ischaemia and infarction. J Clin Pathol (2002) 1.59

XbaI, PstI, and BglII restriction enzyme maps of the two orientations of the varicella-zoster virus genome. J Virol (1981) 1.58

The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol (2004) 1.55

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications. Br J Cancer (2012) 1.53

C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion. Eur J Clin Invest (2004) 1.50

HPV infection in women with and without cervical cancer in Conakry, Guinea. Br J Cancer (2009) 1.50

The c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element. Proc Natl Acad Sci U S A (1992) 1.49

Clinical validation of the cobas 4800 HPV test for cervical screening purposes. J Clin Microbiol (2011) 1.47

Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma. J Pathol (2006) 1.46

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands. Br J Cancer (2006) 1.43

A CD56-negative case of blastic natural killer-cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm). Br J Dermatol (2004) 1.43

Sensitivity of in situ detection with biotinylated probes of human papilloma virus type 16 DNA in frozen tissue sections of squamous cell carcinomas of the cervix. Am J Pathol (1988) 1.43

[Varicella: previously healthy children sometimes develop complications]. Ned Tijdschr Geneeskd (2006) 1.41

[HIV/AIDS in The Netherlands: improved treatment possibilities necessitate HIV instead of AIDS surveillance]. Ned Tijdschr Geneeskd (1997) 1.39

[Grounds for the inclusion of vaccination against cervical cancer within the National Immunisation Programme]. Ned Tijdschr Geneeskd (2008) 1.39

Free viral DNA in BK virus-induced hamster tumor cells. J Virol (1980) 1.38

Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage. Vaccine (1999) 1.38

Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach. Sex Transm Dis (2000) 1.37

Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam. Genitourin Med (1986) 1.36

Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol (2002) 1.36

A quick procedure for purification of functional recombinant proteins over-expressed in E.coli. Nucleic Acids Res (1991) 1.33

Measles outbreak in a community with very low vaccine coverage, the Netherlands. Emerg Infect Dis (2001) 1.33

Sequential gene promoter methylation during HPV-induced cervical carcinogenesis. Br J Cancer (2007) 1.32

[Flat penile lesions in the sexual transmission of human papillomavirus]. Ned Tijdschr Geneeskd (2008) 1.32

A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. J Clin Pathol (2005) 1.31

Cervical cancer screening: on the way to a shift from cytology to full molecular screening. Ann Oncol (2014) 1.30

Evaluating an educational intervention to improve the treatment of asthma in four European countries. Drug Education Project Group. Am J Respir Crit Care Med (1999) 1.28

Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece. Histopathology (2006) 1.28

Effects of stressful daily events on mood states: relationship to global perceived stress. J Pers Soc Psychol (1998) 1.28

Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC. J Pathol (2008) 1.28

Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiol Infect (2005) 1.28

Occupational HIV infection and health care workers in the tropics. Trop Doct (1991) 1.27

Nosocomial infections in a Dutch neonatal intensive care unit: surveillance study with definitions for infection specifically adapted for neonates. J Hosp Infect (2005) 1.26

Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction. J Clin Pathol (2003) 1.25

Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program. J Clin Microbiol (2006) 1.24

High-risk HPV type-specific clearance rates in cervical screening. Br J Cancer (2007) 1.24

Effect of human immunodeficiency virus (HIV) antibody knowledge on high-risk sexual behavior with steady and nonsteady sexual partners among homosexual men. Am J Epidemiol (1989) 1.23

Establishment of a rat cell line inducible for the expression of human cytomegalovirus immediate-early gene products by protein synthesis inhibition. J Virol (1986) 1.23

Mumps epidemic in orthodox religious low-vaccination communities in the Netherlands and Canada, 2007 to 2009. Euro Surveill (2011) 1.22

The complete nucleotide sequence of bovine polyomavirus. J Gen Virol (1990) 1.21

Decline in CD4+ cell numbers reflects increase in HIV-1 replication. AIDS Res Hum Retroviruses (1988) 1.21

Comparison of three different PCR methods for quantifying human papillomavirus type 16 DNA in cervical scrape specimens. J Clin Microbiol (2005) 1.20

Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiol Infect (2002) 1.19

Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands. Math Biosci (2000) 1.17

Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer (2008) 1.17

Antibody response to a synthetic peptide covering a LAV-1/HTLV-IIIB neutralization epitope and disease progression. AIDS (1989) 1.16

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening. Br J Cancer (2008) 1.16